|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02928042 |
|
Date of registration:
|
06/10/2016 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Inhibition Effects of Probiotics on Pathogens Associated With VAP
|
|
Scientific title:
|
Inhibition Effects of Probiotics on Pathogens Associated With Ventilator Associated Pneumonia |
|
Date of first enrolment:
|
November 2016 |
|
Target sample size:
|
80 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02928042 |
|
Study type:
|
Observational [Patient Registry] |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Turkey
| | | | | | | |
|
Contacts
|
|
Name:
|
Dilek Özcengiz, Professor |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Cukurova University |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients who mechanically ventilated at least 48 hours in the intensive care unit
Exclusion Criteria:
- Patients who mechanically ventilated less than 48 hours
Age minimum:
18 Years
Age maximum:
80 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Ventilator Associated Pneumonia
|
|
Intervention(s)
|
|
Other: Lactobacillus bacteria
|
|
Primary Outcome(s)
|
|
Probiotics' antimicrobial properties and effects on P. aeruginosa, A. baumanii, Staph. auresu and K. pneumonia's growth rate.
[Time Frame: 7 months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|